A Double-Blind Comparison of Moxonidine and Atenolol in the Management of Patients with Mild-to-Moderate Hypertension

The safety and efficacy of moxonidine, a new imidazoline receptor modulator, were compared with those of atenolol in 63 patients with mild-to-moderate essential hypertension in a multicenter, randomized, double-blind, parallel-group trial. The study consisted of a 4-week singleblind placebo run-in p...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of cardiovascular pharmacology 1992, Vol.20 Suppl 4 (Supplement 4), p.S45-S49
Hauptverfasser:	Prichard, B N. C, Simmons, R, Rooks, Marie J, Haworth, D A, Laws, D, Wonnacott, S
Format:	Artikel
Sprache:	eng
Schlagworte:	Antihypertensive agents Biological and medical sciences Cardiovascular system Medical sciences Pharmacology. Drug treatments
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!